Showing results (261-270 of 268) with videos related to
Sort By:
Pageof 27
You have reached the last page of results.This site can display upto 268 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 18, 2024
Survival benefit of adjuvant chemotherapy based on molecular residual disease detection in resected colorectal liver metastases: subgroup analysis from CIRCULATE-Japan GALAXYK Kataoka, K Mori, Y Nakamura, et al.Leukemia|April 9, 2016
Genetic alterations and their clinical implications in older patients with acute myeloid leukemiaC-H Tsai, H-A Hou, J-L Tang, et al.Blood Cancer Journal|January 21, 2014
Dynamics of ASXL1 mutation and other associated genetic alterations during disease progression in patients with primary myelodysplastic syndromeT-C Chen, H-A Hou, W-C Chou, et al.Leukemia|August 10, 2013
Integration of cytogenetic and molecular alterations in risk stratification of 318 patients with de novo non-M3 acute myeloid leukemiaH A Hou, C C Lin, W C Chou, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 22, 2021
Predicted sensitivity to endocrine therapy for stage II-III hormone receptor-positive and HER2-negative (HR+/HER2-) breast cancer before chemo-endocrine therapyL Du, C Yau, L Brown-Swigart, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 5, 2022
Treatment Efficacy Score-continuous residual cancer burden-based metric to compare neoadjuvant chemotherapy efficacy between randomized trial arms in breast cancer trialsM Marczyk, A Mrukwa, C Yau, et al.British Journal of Cancer|August 8, 2014
Predicting response and survival in chemotherapy-treated triple-negative breast cancerA Prat, A Lluch, J Albanell, et al.Nature|October 16, 2024
The cool brown dwarf Gliese 229 B is a close binaryJerry W Xuan, A Mérand, W Thompson, et al.Pageof 27